病程4年的无巨核细胞性血小板减少症：抗胸腺细胞球蛋白治疗成功
Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin.
作者信息
Trimble M S, Glynn M F, Brain M C
机构信息
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
出版信息
Am J Hematol. 1991 Jun;37(2):126-7. doi: 10.1002/ajh.2830370212.
PMID:2069157
Abstract
Acquired amegakaryocytic thrombocytopenic purpura (AATP) is a rare cause of thrombocytopenia. Since it is a syndrome of diverse etiologies, the optimal treatment is often uncertain. In a patient with longstanding AATP, a complete remission was obtained with antithymocyte globulin.
摘要
获得性无巨核细胞性血小板减少性紫癜（AATP）是血小板减少的罕见病因。由于它是一种病因多样的综合征，最佳治疗方法往往不确定。在一名长期患有AATP的患者中，使用抗胸腺细胞球蛋白实现了完全缓解。
Zotero 插件